A Review On Anti-Thrombotic Agents Derived From Snake Venom Protein
Main Article Content
Abstract
Snakes have always attracted scientists and it caused awe and fear because of the harmful strength of its toxins and the components of various toxins from one snake to another. In 2017, the World Health Organization (WHO) listed snake venom as a neglected high-priority disease, with snakes causing up to 2.7 million venomous bites, nearly 100,000 victims, and nearly three times the number of human disabilities. Snake venoms are mixtures of various protein components engaged in different functional activities on a variety of physiological target. In this review we will focus on, and the gather updated information about the antithrombotic effect of different snake venoms on their mechanism of action and therapeutic properties.
Objective
- Snake venom background and therapeutics properties.
- The effects of snake bite.
- The mechanism of haemostasis.
- Types of antithrombotic agents derived from snake venom proteins.
Conclusion
Snake venoms are a group of diverse compounds and because of their diversity, they lead to many effects that have different effects on the body, causing an imbalance and mastery of the victim. Just as these components have toxic effects, they have clinical and therapeutic effects. The previous research shown the clinical benefits of snake venom, such as the drug captopril used to treat high blood pressure, And the defibrase used for the prevention of thrombotic disease. Therefore, snake venom components need several studies. They are still unidentified due to the difficulty of obtaining them adequate.